GlassScriptPhysician profile
James S Dunn
NPI 1093700528
$8,479.75
in general payments reported to CMS, 2019-2025
34 companies · $780 in 2025
The $780 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $510 · 2021: $1,881 · 2022: $1,438 · 2023: $1,299 · 2024: $1,900 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,368 · Travel and Lodging: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,367.96 |
| Travel and Lodging | $610.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,277.38 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $1,294.92 | 2019-2025 | Botox, Liletta |
| Coloplast Corp | $1,141.55 | 2020-2024 | Altis, Speedicath |
| Astellas Pharma US INC | $548.91 | 2019-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $520.52 | 2019-2022 | |
| Allergan, INC. | $424.98 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $366.09 | 2023-2025 | Gemtesa, Myfembree |
| Valencia Technologies Corporation | $219.02 | 2025 | Ecoin Device Kit |
| Organon LLC | $206.02 | 2021-2025 | Nexplanon |
| Bluewind Medical | $184.52 | 2024-2025 | Revi |
| Urovant Sciences INC | $149.31 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $146.18 | 2024 | Terlivaz |
| Mayne Pharma Commercial LLC | $126.59 | 2023-2025 | |
| Boston Scientific Corporation | $110.93 | 2020-2023 | Upsylon, Advantage System |
| Lsi Solutions INC | $109.46 | 2023-2024 | Fornisee |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $97.05 | 2025 | |
| Therapeuticsmd, INC. | $67.58 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $65.07 | 2019 | |
| Myovant Sciences INC. | $64.27 | 2021-2022 | |
| 180 Medical, INC. | $52.86 | 2020-2024 | |
| Hologic Sales and Service, LLC | $43.91 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $31.99 | 2019 | |
| Minerva Surgical, INC | $27.29 | 2025 | |
| Axonics, INC. | $26.97 | 2023 | Bulkamid |
| Ethicon US, LLC | $23.81 | 2021 | |
| Becton, Dickinson and Company | $21.68 | 2023 | Bd Onclarity |
| Hologic INC | $19.34 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $19.22 | 2019 | |
| Caldera Medical, INC | $18.10 | 2022 | |
| Lupin INC. | $16.51 | 2019 | |
| Convatec INC. | $14.61 | 2024 | |
| Rochester Medical Corporation | $14.57 | 2021 | |
| Exact Sciences Corporation | $14.57 | 2024 | Cologuard Collection Kit |
| Olympus America INC. | $13.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.